Bringing new medicines to women with epithelial ovarian cancer: what is the unmet medical need?

Por Herzog, Thomas J., Monk, Bradley J.
Publicado no Gynecol Oncol Res Pract (2017)

Gynecologic Oncology Research and Practice: a new journal to meet the needs of a growing field

Por Coleman, Robert L, Herzog, Thomas J, Monk, Bradley J, Dooner, Philip
Publicado no Gynecol Oncol Res Pract (2014)

Updates on drug discovery in ovarian cancer

Por Gibson, Steven J, Tewari, Krishnansu S, Monk, Bradley J, Chase, Dana M
Publicado no Gynecol Oncol Res Pract (2014)

Protein profiling of ovarian cancers by immunohistochemistry to identify potential target pathways

Por Foss, Cassandra D, Dalton, Heather J, Monk, Bradley J, Chase, Dana M, Farley, John H
Publicado no Gynecol Oncol Res Pract (2014)

Safety and efficacy of salvage nano-particle albumin bound paclitaxel in recurrent cervical cancer: a feasibility study

Por Minion, Lindsey E., Chase, Dana M., Farley, John H., Willmott, Lyndsay J., Monk, Bradley J.
Publicado no Gynecol Oncol Res Pract (2016)

New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical care

Por Talhouk, A., McAlpine, J. N.
Publicado no Gynecol Oncol Res Pract (2016)

Breaking down the evidence for bevacizumab in advanced cervical cancer: past, present and future

Por Rodriguez-Freixinos, Victor, Mackay, Helen J.
Publicado no Gynecol Oncol Res Pract (2015)

Therapeutic options for treatment of human papillomavirus-associated cancers - novel immunologic vaccines: ADXS11–001

Por Miles, Brett, Safran, Howard P., Monk, Bradley J.
Publicado no Gynecol Oncol Res Pract (2017)

Mechanistic insights into ADXS11-001 human papillomavirus-associated cancer immunotherapy

Por Miles, Brett A., Monk, Bradley J., Safran, Howard P.
Publicado no Gynecol Oncol Res Pract (2017)

In vitro chemoresponse in metachronous pairs of gyneclologic cancers

Por Dalton, Heather J, Fiorica, James, McClure, Candace K, Rocconi, Rodney P, Recio, Fernando O, Levocchio, John L, Burrell, Matthew O, Monk, Bradley J
Publicado no Gynecol Oncol Res Pract (2014)

Will bevacizumab biosimilars impact the value of systemic therapy in gynecologic cancers?

Por Monk, Bradley J., Huh, Warner K., Rosenberg, Julie Ann, Jacobs, Ira
Publicado no Gynecol Oncol Res Pract (2017)

Antiviral Therapy Reduces Viral Burden but Does Not Prevent Thymic Involution in Young Cats Infected with Feline Immunodeficiency Virus

Por Hayes, Kathleen A., Phipps, Andrew J., Francke, Sabine, Mathes, Lawrence E.
Publicado em 2000

Suberoylanilide Hydroxamic Acid (SAHA) enhances olaparib activity by targeting homologous recombination DNA repair in ovarian cancer

Por Konstantinopoulos, Panagiotis A., Wilson, Andrew J., Saskowski, Jeanette, Wass, Erica, Khabele, Dineo
Publicado no Gynecol Oncol (2014)

Molecular Mechanism Linking BRCA1 Dysfunction to High Grade Serous Epithelial Ovarian Cancers with Peritoneal Permeability and Ascites

Por Desai, A, Xu, J, Aysola, K, Akinbobuyi, O, White, M, Reddy, VE, Okoli, J, Clark, C, Partridge, EE, Childs, Ed, Beech, DJ, Rice, MV, Reddy, ESP, Rao, VN
Publicado no J Gynecol Res (2015)

Impact of cervical cancer on quality of life: beyond the short term (Results from a single institution): Quality of life in long-term cervical cancer survivors: results from a sing...

Por Khalil, J., Bellefqih, S., Sahli, N., Afif, M., Elkacemi, H., Elmajjaoui, S., Kebdani, T., Benjaafar, N.
Publicado no Gynecol Oncol Res Pract (2015)

Surgical safety and personal costs in morbidly obese, multimorbid patients diagnosed with early-stage endometrial cancer having a hysterectomy

Por Obermair, Andreas, Brennan, Donal J., Baxter, Eva, Armes, Jane E., Gebski, Val, Janda, Monika
Publicado no Gynecol Oncol Res Pract (2016)

Clinical features and treatment of vulvar Merkel cell carcinoma: a systematic review

Por Nguyen, Austin Huy, Tahseen, Ahmed I., Vaudreuil, Adam M., Caponetti, Gabriel C., Huerter, Christopher J.
Publicado no Gynecol Oncol Res Pract (2017)

Analysis of in vitro chemoresponse assays in endometrioid endometrial adenocarcinoma: an observational ancillary analysis

Por Davidson, Brittany A., Foote, Jonathan, Brower, Stacey L., Tian, Chunqiao, Havrilesky, Laura J., Secord, Angeles Alvarez
Publicado no Gynecol Oncol Res Pract (2016)

Dasatinib (BMS-35482) potentiates the activity of gemcitabine and docetaxel in uterine leiomyosarcoma cell lines

Por Lopez-Acevedo, Micael, Grace, Lisa, Teoh, Deanna, Whitaker, Regina, Adams, David J, Jia, Jingquan, Nixon, Andrew B, Secord, Angeles Alvarez
Publicado no Gynecol Oncol Res Pract (2014)

Multidisciplinary approach to manage antenatally suspected placenta percreta: updated algorithm and patient outcomes

Por Lee, Paula S., Kempner, Samantha, Miller, Michael, Dominguez, Jennifer, Grotegut, Chad, Ehrisman, Jessie, Previs, Rebecca, Havrilesky, Laura J., Broadwater, Gloria, Ellestad, Sarah C., Secord, Angeles Alvarez
Publicado no Gynecol Oncol Res Pract (2017)